Wong VW, Ekstedt M, Wong GL, Hagström H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79:842–852
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–209
Zhang L, El-Shabrawi M, Baur LA, et al (2024) An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease. Med (New York, NY)
Kucukoglu O, Sowa JP, Mazzolini GD, Syn WK, Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol. 2021;74:442–457
Article CAS PubMed Google Scholar
Boutari C, Mantzoros CS. Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism Clin Exp. 2020;103:154028
Flippo KH, Potthoff MJ. Metabolic messengers: FGF21. Nat Metab. 2021;3:309–317
Article CAS PubMed PubMed Central Google Scholar
Mantovani A, Tilg H, Targher G. FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials. Gut. 2024;73:1400–1402
Makri ES, Evripidou K, Polyzos SA. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis. J Gastroenterol Hepatol. 2024;39:806–817
Article CAS PubMed Google Scholar
Tontikidou C, Makri ES, Evripidou K, Goulis DG, Goulas A, Polyzos SA. Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis. J Gastroenterol Hepatol. 2022;37:1853–1864
Article CAS PubMed Google Scholar
Hu R, Yang X, He X, Song G. The relationship between NAFLD and retinol-binding protein 4—an updated systematic review and meta-analysis. Lipids Health Dis. 2023;22:8
Article CAS PubMed PubMed Central Google Scholar
Ke Y, Liu S, Zhang Z, Hu J. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids Health Dis. 2021;20:55
Article CAS PubMed PubMed Central Google Scholar
Mikami K, Endo T, Sawada N, et al. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population. Cytokine. 2020;126: 154927
Article CAS PubMed Google Scholar
Liu D, Wu L, Gao Q, et al. FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China. Cardiovasc Diabetol. 2021;20:157
Article PubMed PubMed Central Google Scholar
Jialal I, Adams-Huet B, Duong F, Smith G. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation. Metab Syndr Relat Disord. 2014;12:227–230
Article CAS PubMed Google Scholar
Li G, Esangbedo IC, Xu L, et al. Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study. Cardiovasc Diabetol. 2018;17:69
Article CAS PubMed PubMed Central Google Scholar
Fu J, Hou C, Li L, et al. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome. Cardiovasc Diabetol. 2016;15:142
Article PubMed PubMed Central Google Scholar
Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010;52:579–585
Article CAS PubMed Google Scholar
Hayes AF, Preacher KJ. Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol. 2014;67:451–470
Suomela E, Oikonen M, Pitkänen N, et al. Childhood predictors of adult fatty liver. The cardiovascular risk in young finns study. J Hepatol. 2016;65:784–790
Polyzos SA, Aronis KN, Kountouras J, Raptis DD, Vasiloglou MF, Mantzoros CS. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia. 2016;59:30–43
Article CAS PubMed Google Scholar
Zhao S, Zhu Y, Schultz RD, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 2019;30:706–19.e6
Article CAS PubMed PubMed Central Google Scholar
Shabalala SC, Dludla PV, Mabasa L, et al. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedic Pharmacother. 2020;131:110785
Kim YS, Lee SH, Park SG, et al. Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults. Metabolism Clin Exp. 2020. https://doi.org/10.1016/j.metabol.2019.154026
Hui X, Feng T, Liu Q, Gao Y, Xu A. The FGF21-adiponectin axis in controlling energy and vascular homeostasis. J Mol Cell Biol. 2016;8:110–119
Article CAS PubMed Google Scholar
Tas E, Bai S, Ou X, et al. Fibroblast growth factor-21 to adiponectin ratio: a potential biomarker to monitor liver fat in children with obesity. Front Endocrinol. 2020;11:654
Huang H, Xu C. Retinol-binding protein-4 and nonalcoholic fatty liver disease. Chin Med J. 2022;135:1182–1189
Article CAS PubMed PubMed Central Google Scholar
Wang X, Chen X, Zhang H, et al. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease. Diabetes Metab. 2020;46:119–128
Article CAS PubMed Google Scholar
Vatner DF, Goedeke L, Camporez JG, et al. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia. 2018;61:1435–1446
Article CAS PubMed PubMed Central Google Scholar
Hammad MM, Channanath AM, Abu-Farha M, et al. Adolescent obesity and ANGPTL8: correlations with high sensitivity C-reactive protein, leptin, and chemerin. Front Endocrinol. 2023;14:1314211
Stefan N, Schick F, Birkenfeld AL, Häring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35:236–252
留言 (0)